Ibuprofen lysinate pharmaceutical formulation

Details Ibuprofen lysinate pharmaceutical formulation Ibuprofen lysinate pharmaceutical formulation

1992-05-01

1997-04-22

Cook, Rebecca

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514534, 514548, 514570, A01N 3110, A61K 31235

Patent

active

056229909

ABSTRACT:
Pharmaceutical ibuprofen lysinate dry granulation formulations comprising about 90% w/w ibuprofen lysinate are useful for the preparation of tablets containing ibuprofen lysinate.

REFERENCES:
patent: 4279926 (1981-07-01), Bruzzese et al.
patent: 4609675 (1986-09-01), Franz
patent: 4994604 (1991-02-01), Tung et al.
patent: 5087454 (1992-02-01), Duerholz et al.
Lieberman and Lachman, Pharmaceutical Dosage Forms: Tablets; 1, 61-107 (1980, Marcel Dekker, N.Y.).
Pharmaceutical Dosage Forms: Tablets; 1, 61-107 (1980) Marcel Dekker, N.Y.
The Merck Index, Monographs No. 1961, (11th ed., New Jersey, Merck & Co., Inc., 1989).
Handbook of Pharmaceutical Excipients, (Published by American Association).
The Merck Index, Monographs Nos. 3521 and 5393, (11th ed., N.J., Merck & Co., Inc., 1989).
Physicians Desk Reference, PDR.RTM. 43ed., 1384 and 1408, (1989).

Affiliated with

Also associated with

Rating

Ibuprofen lysinate pharmaceutical formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ibuprofen lysinate pharmaceutical formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ibuprofen lysinate pharmaceutical formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-342156